Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Biosystems ; 105(3): 181-9, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21477635

RESUMO

We study the correlation of the occurrence of coronary heart disease (CHD) with the presence of the single-nucleotide polymorphism (SNP) at the -308 position of the tumor necrosis factor alpha (TNF-α) gene. We also consider the influence of the occurrence of type 2 diabetes (t2DM). Using Bayesian inference, we first pursue a bottom-up approach to compute the working hypothesis and the probabilities derivable from the data. We then pursue a top-down approach by modelling the signal pathway that causally connects the SNP with the emergence of CHD. We compute the functional form of the probability of CHD conditional on the presence of the SNP in terms of both the statistical and biochemical properties of the system. From the probability of occurrence of a disease conditional on a given risk factor, we explore the possibility of extracting information on the pathways involved in the occurrence of the disease. This is a first study that we want to systematise into a comprehensive formalism to be applied to the inference of the mechanism connecting the risk factors to the disease.


Assuntos
Doença das Coronárias/epidemiologia , Doença das Coronárias/genética , Diabetes Mellitus Tipo 2/epidemiologia , Fator de Necrose Tumoral alfa/genética , Teorema de Bayes , Humanos , Modelos Biológicos , Polimorfismo de Nucleotídeo Único , Probabilidade , Fatores de Risco , Transdução de Sinais
2.
J Am Med Inform Assoc ; 16(6): 802-5, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19717805

RESUMO

The authors developed "DIET", a computerized system preparing dietary prescriptions in clinical settings. "DIET" has the ability to calculate the nutritional requirements and to produce daily menus of patients automatically. Also, it serves as an electronic medical and dietetic record and it can produce daily reports regarding portions, quantities and cost of meals. The authors also conducted a preliminary evaluation of the system by comparing the design of nutritional plans for 135 patients using "DIET" versus the customary manual methods. Its use resulted in a decrease of the error percentages, concerning appropriate food choices, data recording and calculations of daily nutrient requirements; from 12% to 1.5%. Additionally, there was a reduction by 50% of the time required to obtain and process data as well as design a patient's menu. "DIET" implementation resulted in error decrease and thus in improvement of menu planning, accuracy and recovery of data and decreased the time spent on menu planning.


Assuntos
Tomada de Decisões Assistida por Computador , Dietoterapia , Serviço Hospitalar de Nutrição , Planejamento de Cardápio , Avaliação de Resultados em Cuidados de Saúde , Adulto , Algoritmos , Dietética , Grécia , Humanos
3.
Pharm World Sci ; 31(2): 202-8, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19169838

RESUMO

OBJECTIVE: Total parenteral nutrition is commonly used in neonates' intensive care units for nutritional support of preterm neonates. Adequacy and safety of parenteral nutrition support are amongst the major concerns of neonates' therapy. Parenteral nutrition prescription in Greek hospitals is not based on standardized protocols, thus resulting in wide diversity of formulations. In this study, the results of utilization of standardized computerized parenteral nutrition protocols and regimens for neonates are compared to the results of protocols and regimens prescribed by individual neonatologists on neonates' outcome (weight changes, adequacy of parenteral nutrition, days of hospitalization, clinical outcome). SETTING: The study took place at "Mitera" Maternity Hospital of Greece. METHOD: Two groups of 30 preterm infants (28-36 weeks) with respiratory failure were recruited for the study. They were admitted in a Greek maternity hospital and they all received total parenteral nutrition support in neonates' intensive care unit. Standardized, computer based protocols were applied for the prescription of parenteral nutrition formulations in the first group, while on the other, regimens prescribed by neonatologists were used. MAIN OUTCOME MEASURES: Macro- and micronutrients provided by the different total parenteral nutrition protocols were recorded. Body weight was measured, blood count and biochemical profile were performed at the beginning and at the end of parenteral nutrition support. The number of days of total parenteral nutrition support as well as the total number of days of hospitalization was recorded. RESULTS: Standardized protocols provided more energy (P-value: 0.05), protein (P-value: 0.023) and micronutrients than the non-standardised. Neonates that receive standardized total parenteral nutrition gained weight (+44 +/- 114 g) and had better blood count and biochemical values during total parenteral nutrition support compared to the other group, that lost weight during total parenteral nutrition support (-53 +/- 156 g). These differences were also statistically significant (P value < 0.05). Regarding the total days of hospitalization, no differences were found between the two groups. CONCLUSION: The use of standardized protocols in preterm neonates resulted in more adequate provision of nutrients, weight gain and better blood count profile compared with protocols prescribed by individual physicians.


Assuntos
Recém-Nascido Prematuro , Nutrição Parenteral Total/métodos , Nutrição Parenteral Total/normas , Terapia Assistida por Computador/métodos , Biomarcadores/análise , Protocolos Clínicos/normas , Humanos , Recém-Nascido , Tempo de Internação , Avaliação Nutricional , Nutrição Parenteral Total/efeitos adversos , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia , Resultado do Tratamento , Aumento de Peso
4.
Expert Opin Ther Targets ; 12(8): 937-48, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18620517

RESUMO

BACKGROUND: CETP has an established role in the transport of cholesterol from the peripheral tissues to the liver for elimination. The fact that CETP was recognized as a target for raising high-density lipoprotein cholesterol (HDL-C) levels has led to research on CETP inhibitors to protect against atherosclerosis. OBJECTIVE: To review the role of CETP as a pivotal target for atherosclerosis and cardiovascular diseases and the effect of its overexpression or inhibition on lipid metabolism. METHODS: A review of literature on the role of CETP in cholesterol metabolism and on recent developments on CETP inhibitors. RESULTS/CONCLUSIONS: Animal and human studies have provided evidence supporting both the pro- and antiatherogenic roles of CETP. Clinical trials with CETP inhibitors remain under serious consideration. Further studies are necessary for understanding of the role of CETP in lipid metabolism and the development of novel therapies involving a combination of strategies for treatment of atherosclerosis and cardiovascular disease.


Assuntos
Aterosclerose/prevenção & controle , Proteínas de Transferência de Ésteres de Colesterol/antagonistas & inibidores , Hipolipemiantes/farmacologia , Animais , Proteínas de Transferência de Ésteres de Colesterol/genética , Proteínas de Transferência de Ésteres de Colesterol/metabolismo , Desenho de Fármacos , Humanos , Hipolipemiantes/química , Camundongos , Polimorfismo Genético , Coelhos
5.
Phys Rev E Stat Nonlin Soft Matter Phys ; 76(1 Pt 1): 011926, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17677513

RESUMO

In this paper we use a simple model to explore the function of the gene Osteosarcoma-9 (OS-9). We are particularly interested in understanding the role of this gene as a potent anti-apoptotic factor. The theoretical description is constrained by experimental data from induction of apoptosis in cells where OS-9 is overexpressed. The data available suggest that OS-9 promotes cell viability and confers resistance to apoptosis, potentially implicating OS-9 in the survival of cancer cells. Three different apoptosis-inducing mechanisms were tested and are modeled here. A more complex and realistic model is also discussed.


Assuntos
Apoptose/fisiologia , Sobrevivência Celular/fisiologia , Modelos Biológicos , Modelos Químicos , Proteínas de Neoplasias/química , Proteínas de Neoplasias/metabolismo , Simulação por Computador , Lectinas
6.
Angiogenesis ; 7(2): 143-56, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15516835

RESUMO

We recently published a review in this journal describing the design, hybridisation and basic data processing required to use gene arrays to investigate vascular biology (Evans et al. Angiogenesis 2003; 6: 93-104). Here, we build on this review by describing a set of powerful and robust methods for the analysis and interpretation of gene array data derived from primary vascular cell cultures. First, we describe the evaluation of transcriptome heterogeneity between primary cultures derived from different individuals, and estimation of the false discovery rate introduced by this heterogeneity and by experimental noise. Then, we discuss the appropriate use of Bayesian t-tests, clustering and independent component analysis to mine the data. We illustrate these principles by analysis of a previously unpublished set of gene array data in which human umbilical vein endothelial cells (HUVEC) cultured in either rich or low-serum media were exposed to vascular endothelial growth factor (VEGF)-A165 or placental growth factor (PlGF)-1(131). We have used Affymetrix U95A gene arrays to map the effects of these factors on the HUVEC transcriptome. These experiments followed a paired design and were biologically replicated three times. In addition, one experiment was repeated using serial analysis of gene expression (SAGE). In contrast to some previous studies, we found that VEGF-A and PlGF consistently regulated only small, non-overlapping and culture media-dependant sets of HUVEC transcripts, despite causing significant cell biological changes.


Assuntos
Biologia Computacional , Endotélio Vascular/citologia , Perfilação da Expressão Gênica , Proteínas da Gravidez/farmacologia , Transcrição Gênica/efeitos dos fármacos , Fator A de Crescimento do Endotélio Vascular/farmacologia , Células Cultivadas , Meios de Cultura/farmacologia , Endotélio Vascular/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Fator de Crescimento Placentário , Reação em Cadeia da Polimerase , Proteínas/genética , Reprodutibilidade dos Testes , Veias Umbilicais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA